We are live on !
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$4.34B
AUM Growth
+$534M
(+14%)
Cap. Flow
+$223M
Cap. Flow % of AUM
Cap. Flow %
5.15%
Top 10 Holdings %
Top 10 Hldgs %
29.74%
Holding
1,612
New
75
Increased
544
Reduced
448
Closed
76
Avg Time Held
4
years
Top 10 Avg Time Held
3.7
years
Top 20 Avg Time Held
3.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$24.6M |
| 2 |
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
|
+$16.4M |
| 3 |
Fidelity Total Bond ETF
FBND
|
+$16.1M |
| 4 |
iShares Systematic Alternatives Active ETF
IALT
|
+$16M |
| 5 |
iShares Core Universal USD Bond ETF
IUSB
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$7.72M |
| 2 |
Citigroup
C
|
+$7.28M |
| 3 |
iShares Gold Trust
IAU
|
+$6.25M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.23M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$6.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 76.75% |
| 2 | Technology | 5.6% |
| 3 | Financials | 4.52% |
| 4 | Industrials | 2.67% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Thermo Fisher Scientific
TMO
$252B
| $3.34M | 0.08% |
6,670
-231
| -3% | -$111K |
2015 Q4
42 quarters
|
|
202
Invesco S&P 500 Equal Weight ETF
RSP
$100B
| $3.33M | 0.08% |
15,673
+490
| +3% | +$100K |
2017 Q1
37 quarters
|
|
203
Eaton
ETN
$145B
| $3.31M | 0.08% |
7,771
-60
| -0.8% | -$24.2K |
2019 Q1
29 quarters
|
|
204
iShares US Medical Devices ETF
IHI
$3.59B
| $3.28M | 0.08% |
66,463
-4,148
| -6% | -$211K |
2021 Q1
21 quarters
|
|
205
Goldman Sachs ETF Trust Goldman Sachs Nasdaq-100 Premium Income ETF
GPIQ
$6.34B
| $3.25M | 0.07% |
54,840
+28,239
| +106% | +$1.59M |
2025 Q2
4 quarters
|
|
206
MetLife
MET
$63.6B
| $3.24M | 0.07% |
38,262
+129
| +0.3% | +$10.4K |
2013 Q2
52 quarters
|
|
207
Citizens Financial Group
CFG
$27.7B
| $3.24M | 0.07% |
46,156
-821
| -2% | -$52.9K |
2016 Q1
41 quarters
|
|
208
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$16B
| $3.21M | 0.07% |
55,683
-5,981
| -10% | -$319K |
2018 Q4
30 quarters
|
|
209
iShares Russell 1000 Growth ETF
IWF
$124B
| $3.2M | 0.07% |
25,811
+63
| +0.2% | +$7.6K |
2018 Q1
33 quarters
|
|
210
Capital Group Global Equity ETF
CGGE
$3.23B
| $3.17M | 0.07% |
89,985
+41,758
| +87% | +$1.4M |
2025 Q1
5 quarters
|
|
211
Danaher
DHR
$164B
| $3.16M | 0.07% |
16,597
-34
| -0.2% | -$6.17K |
2018 Q4
30 quarters
|
|
212
American Century US Quality Growth ETF
QGRO
$1.93B
| $3.16M | 0.07% |
26,725
-1,063
| -4% | -$121K |
2022 Q4
14 quarters
|
|
213
Vanguard US Minimum Volatility ETF
VFMV
$484M
| $3.15M | 0.07% |
22,575
+2,043
| +10% | +$284K |
2025 Q3
3 quarters
|
|
214
iShares Short Duration High Yield Muni Active ETF
SHYM
$913M
| $3.1M | 0.07% |
137,977
-2,387
| -2% | -$53K |
2025 Q2
4 quarters
|
|
215
Synopsys
SNPS
$87B
| $3.02M | 0.07% |
6,778
-500
| -7% | -$235K |
2018 Q1
33 quarters
|
|
216
iShares International Dividend Growth ETF
IGRO
$1.3B
| $3.02M | 0.07% |
34,287
+2,436
| +8% | +$213K |
2023 Q3
11 quarters
|
|
217
Calamos Autocallable Income ETF
CAIE
$1.28B
| $3.02M | 0.07% |
110,811
+289
| +0.3% | +$7.78K |
2025 Q3
3 quarters
|
|
218
iShares 7-10 Year Treasury Bond ETF
IEF
$41.5B
| $3.01M | 0.07% |
31,804
-854
| -3% | -$80.8K |
2019 Q3
27 quarters
|
|
219
Schwab Emerging Markets Equity ETF
SCHE
$12.3B
| $3.01M | 0.07% |
82,960
+17,531
| +27% | +$626K |
2024 Q1
9 quarters
|
|
220
T-Mobile US
TMUS
$157B
| $2.98M | 0.07% |
17,774
-650
| -4% | -$123K |
2021 Q1
21 quarters
|
|
221
Newmont
NEM
$114B
| $2.91M | 0.07% |
31,169
-155
| -0.5% | -$16.9K |
2019 Q2
28 quarters
|
|
222
State Street Technology Select Sector SPDR ETF
XLK
$123B
| $2.89M | 0.07% |
15,178
-215
| -1% | -$36.7K |
2020 Q3
23 quarters
|
|
223
Emerson Electric
EMR
$90.6B
| $2.87M | 0.07% |
20,041
-66
| -0.3% | -$9.29K |
2017 Q3
35 quarters
|
|
224
Capital Group Core Equity ETF
CGUS
$12.1B
| $2.86M | 0.07% |
64,187
+24,126
| +60% | +$1.03M |
2023 Q3
11 quarters
|
|
225
FT Vest Rising Dividend Achievers Target Income ETF
RDVI
$3.78B
| $2.85M | 0.07% |
97,070
+6,567
| +7% | +$181K |
2023 Q2
12 quarters
|
|
Similar funds
Capital Analysts LLC's Q2 2026 Portfolio in Review
As of Q2 2026, Capital Analysts LLC held 1,612 positions worth $4.34B, up 14% from $3.81B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Analysts LLC deployed $223M of net new capital in Q2 2026, opening 75 new positions and adding to 544 existing holdings. Its largest new stake was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, up from 75% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Zoetis, an estimated $7.72M trimmed.
- Capital Analysts LLC's largest Q2 2026 buy was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
- Capital Analysts LLC added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $24.6M increase.
- Capital Analysts LLC's biggest Q2 2026 reduction was Zoetis, cutting an estimated $7.72M.
- Capital Analysts LLC fully exited Hershey in Q2 2026, selling an estimated $113K.
- Capital Analysts LLC's ten largest holdings make up 30% of its $4.34B portfolio in Q2 2026.
- Capital Analysts LLC opened 75 new positions and closed 76 in Q2 2026.
- Capital Analysts LLC's portfolio value rose 14% quarter-over-quarter to $4.34B.
Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.